| Date | Time | Source | Headline | Symbol | Company |
| 14/02/2018 | 22:54 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:OCRX | Ocera Therapeutics, Inc. (MM) |
| 14/02/2018 | 19:53 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:OCRX | Ocera Therapeutics, Inc. (MM) |
| 21/12/2017 | 21:26 | Edgar (US Regulatory) | Termination of Registration of a Class of Security Under Section 12(b) (15-12b) | NASDAQ:OCRX | Ocera Therapeutics, Inc. (MM) |
| 21/12/2017 | 11:04 | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (sc 13d/a) | NASDAQ:OCRX | Ocera Therapeutics, Inc. (MM) |
| 14/12/2017 | 17:08 | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (sc 13d/a) | NASDAQ:OCRX | Ocera Therapeutics, Inc. (MM) |
| 14/12/2017 | 11:01 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:OCRX | Ocera Therapeutics, Inc. (MM) |
| 14/12/2017 | 11:01 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:OCRX | Ocera Therapeutics, Inc. (MM) |
| 14/12/2017 | 11:01 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:OCRX | Ocera Therapeutics, Inc. (MM) |
| 13/12/2017 | 22:00 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OCRX | Ocera Therapeutics, Inc. (MM) |
| 13/12/2017 | 21:54 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OCRX | Ocera Therapeutics, Inc. (MM) |
| 13/12/2017 | 21:44 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OCRX | Ocera Therapeutics, Inc. (MM) |
| 13/12/2017 | 21:40 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OCRX | Ocera Therapeutics, Inc. (MM) |
| 13/12/2017 | 21:33 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OCRX | Ocera Therapeutics, Inc. (MM) |
| 11/12/2017 | 20:26 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OCRX | Ocera Therapeutics, Inc. (MM) |
| 11/12/2017 | 20:26 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OCRX | Ocera Therapeutics, Inc. (MM) |
| 11/12/2017 | 20:26 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OCRX | Ocera Therapeutics, Inc. (MM) |
| 11/12/2017 | 20:25 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OCRX | Ocera Therapeutics, Inc. (MM) |
| 11/12/2017 | 20:24 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OCRX | Ocera Therapeutics, Inc. (MM) |
| 11/12/2017 | 20:21 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OCRX | Ocera Therapeutics, Inc. (MM) |
| 11/12/2017 | 20:21 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OCRX | Ocera Therapeutics, Inc. (MM) |
| 11/12/2017 | 20:20 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OCRX | Ocera Therapeutics, Inc. (MM) |
| 11/12/2017 | 20:20 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OCRX | Ocera Therapeutics, Inc. (MM) |
| 11/12/2017 | 15:26 | Edgar (US Regulatory) | Post-effective Amendment to Registration Statement (pos Am) | NASDAQ:OCRX | Ocera Therapeutics, Inc. (MM) |
| 11/12/2017 | 15:26 | Edgar (US Regulatory) | Post-effective Amendment to Registration Statement (pos Am) | NASDAQ:OCRX | Ocera Therapeutics, Inc. (MM) |
| 11/12/2017 | 15:23 | Edgar (US Regulatory) | Post-effective Amendment to Registration Statement (pos Am) | NASDAQ:OCRX | Ocera Therapeutics, Inc. (MM) |
| 11/12/2017 | 15:22 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:OCRX | Ocera Therapeutics, Inc. (MM) |
| 11/12/2017 | 15:19 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:OCRX | Ocera Therapeutics, Inc. (MM) |
| 11/12/2017 | 15:18 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:OCRX | Ocera Therapeutics, Inc. (MM) |
| 11/12/2017 | 15:16 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:OCRX | Ocera Therapeutics, Inc. (MM) |
| 11/12/2017 | 15:13 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:OCRX | Ocera Therapeutics, Inc. (MM) |